CurifyLabs has raised a total of €17.6 million in funding and is positioned for substantial growth in the US market, where the majority of compounding manufacturing occurs.
Founders
Charlotta Topelius, Niklas Sandler Topelius
Company Description
CurifyLabs aims to disrupt the outdated, error-prone compounding process that serves millions, including children and cancer patients who can’t take standard medications. The company has developed a solution to automate the manufacturing of compounded medicine, making the process four times faster and enabling limitless dosing flexibility.